We are live on !
Find out more
Davidson & Garrard Portfolio holdings
AUM
$425M
Turnover
4.35%
1-Year Est. Return
14.62%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+14.62%
3 Year Est. Return
+25.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$411M
AUM Growth
-$5.17M
(-1.2%)
Cap. Flow
-$980K
Cap. Flow % of AUM
Cap. Flow %
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
191
New
4
Increased
80
Reduced
72
Closed
12
Avg Time Held
1.1
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.55M |
| 2 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$1.29M |
| 3 |
Invensense Inc
INVN
|
+$647K |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$599K |
| 5 |
Cummins
CMI
|
+$345K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$2.04M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$888K |
| 3 |
American Airlines Group
AAL
|
+$876K |
| 4 |
eBay
EBAY
|
+$825K |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$584K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.97% |
| 2 | Healthcare | 14.59% |
| 3 | Technology | 13.82% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.06T
| $13.3M | 3.23% |
527,528
-4,452
| -0.8% | -$109K |
2013 Q2
5 quarters
|
|
2
Verizon
VZ
$192B
| $9.6M | 2.34% |
192,795
-1,670
| -0.9% | -$83K |
2013 Q2
5 quarters
|
|
3
iShares Preferred and Income Securities ETF
PFF
$11.5B
| $9.5M | 2.32% |
241,417
+4,409
| +2% | +$175K |
2013 Q2
5 quarters
|
|
4
GE Aerospace
GE
$351B
| $9.17M | 2.23% |
74,692
-1,594
| -2% | -$199K |
2013 Q2
5 quarters
|
|
5
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $9.02M | 2.19% |
169,917
+457
| +0.3% | +$23.9K |
2013 Q2
5 quarters
|
|
6
CVS Health
CVS
$114B
| $8.82M | 2.14% |
110,815
-203
| -0.2% | -$16K |
2013 Q2
5 quarters
|
|
7
ExxonMobil
XOM
$671B
| $8M | 1.95% |
85,114
-180
| -0.2% | -$17.9K |
2013 Q2
5 quarters
|
|
8
Thermo Fisher Scientific
TMO
$266B
| $7.07M | 1.72% |
58,065
-1,399
| -2% | -$170K |
2013 Q2
5 quarters
|
|
9
PepsiCo
PEP
$196B
| $6.95M | 1.69% |
74,696
+239
| +0.3% | +$21.8K |
2013 Q2
5 quarters
|
|
10
Intel
INTC
$309B
| $6.73M | 1.64% |
193,272
-1,024
| -0.5% | -$34.7K |
2013 Q2
5 quarters
|
|
11
AT&T
T
$148B
| $6.7M | 1.63% |
251,539
-2,774
| -1% | -$73.8K |
2013 Q2
5 quarters
|
|
12
Procter & Gamble
PG
$391B
| $6.54M | 1.59% |
78,057
+326
| +0.4% | +$26.7K |
2013 Q2
5 quarters
|
|
13
McKesson
MCK
$125B
| $6.44M | 1.57% |
33,081
-1,420
| -4% | -$273K |
2013 Q2
5 quarters
|
|
14
Bank of America
BAC
$350B
| $6M | 1.46% |
352,221
+7,329
| +2% | +$117K |
2013 Q2
5 quarters
|
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $5.84M | 1.42% |
82,738
+1,685
| +2% | +$120K |
2013 Q2
5 quarters
|
|
16
IBM
IBM
$231B
| $5.83M | 1.42% |
32,139
-1,816
| -5% | -$331K |
2013 Q2
5 quarters
|
|
17
Microsoft
MSFT
$3.96T
| $5.83M | 1.42% |
125,725
+1,755
| +1% | +$78.3K |
2013 Q2
5 quarters
|
|
18
Johnson & Johnson
JNJ
$676B
| $5.66M | 1.37% |
53,068
+84
| +0.2% | +$8.71K |
2013 Q2
5 quarters
|
|
19
JPMorgan Chase
JPM
$908B
| $5.56M | 1.35% |
92,256
+4
| +0% | +$234 |
2013 Q2
5 quarters
|
|
20
Becton Dickinson
BDX
$57.9B
| $5.51M | 1.34% |
49,611
+66
| +0.1% | +$7.53K |
2013 Q2
5 quarters
|
|
21
NNN REIT
NNN
$8.1B
| $5.47M | 1.33% |
158,162
-926
| -0.6% | -$33.9K |
2013 Q2
5 quarters
|
|
22
DELISTED
Spectra Energy Corp Wi
SE
| $5.38M | 1.31% |
137,060
-1,412
| -1% | -$58.1K |
2013 Q2
5 quarters
|
|
23
Microchip Technology
MCHP
$32.8B
| $5.35M | 1.3% |
226,666
+26
| +0% | +$622 |
2013 Q2
5 quarters
|
|
24
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $5.18M | 1.26% |
189,260
+5,735
| +3% | +$162K |
2013 Q2
5 quarters
|
|
25
Merck
MRK
$365B
| $5.13M | 1.25% |
90,740
+431
| +0.5% | +$24.2K |
2013 Q2
5 quarters
|
|
Similar funds
SD
MCL
GIIO
JPCCM
Davidson & Garrard's Q3 2014 Portfolio in Review
As of Q3 2014, Davidson & Garrard held 191 positions worth $411M, down 1.2% from $417M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Davidson & Garrard's Q3 2014 filing shows 4 new, 80 increased, 72 reduced and 12 closed positions. Its largest new stake was DONNELLEY R R & SONS CO: 78,214 shares worth $1.29M. The largest sale was iShares Russell 2000 ETF, an estimated $2.04M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.
- Davidson & Garrard's largest Q3 2014 buy was DONNELLEY R R & SONS CO: 78,214 shares worth $1.29M.
- Davidson & Garrard added most to AbbVie in Q3 2014, an estimated $3.55M increase.
- Davidson & Garrard's biggest Q3 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $2.04M.
- Davidson & Garrard fully exited American Airlines Group in Q3 2014, selling an estimated $876K.
- Davidson & Garrard's ten largest holdings make up 21% of its $411M portfolio in Q3 2014.
- Davidson & Garrard opened 4 new positions and closed 12 in Q3 2014.
- Davidson & Garrard's portfolio value fell 1.2% quarter-over-quarter to $411M.
Based on Davidson & Garrard's 13F filing for Q3 2014, filed 6 Nov 2014.